Search - tctmd.com

Displaying 121 - 140 of 140

Sort: Relevancy | Date

News Industry News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

September 12, 2013

News Industry News

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

November 29, 2012

Presentation TCT 2012

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

Presenter: Dean Kereiakes

October 25, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

Presentation TCT 2012

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

Presenter: Dean J. Kereiakes, Louis A. Cannon, John A. Ormiston, Hong Wang, Paul L. Underwood, Keith D. Dawkins

January 03, 2012

Presentation TCT 2012

Long-Term Follow-up of the Platinum Chromium TAXUS Element (ION) Stent: PERSEUS Two-Year Results.

Presenter: Louis A. Cannon, Dean J. Kereiakes, Wayne Batchelor, Albert Deibele, James Hopkins, Robert E. Foster, Paul Underwood, Keith D. Dawkins

January 03, 2012

News Conference News

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

November 06, 2011

News Industry News

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

May 25, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Industry News

Boston Scientific Announces its ACC 2011 Schedule

March 29, 2011

News Industry News

Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent

January 25, 2011

Video

» Interview

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

October 18, 2020

Video

» Interview

DISRUPT CAD III: A deep dive on the U.S. pivotal study for coronary IVL

October 16, 2020

Partner Content

TopShock 2019: The Most Challenging Cases Simplified With IVL - Shockwave Medical

December 11, 2019

Partner Content

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

May 17, 2019

Partner Content

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - OUS

April 23, 2019

Partner Content

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - US

April 23, 2019

Partner Content

Expanding Treatment Options for Patients with Severe Aortic Stenosis: The Lotus and ACURATE neo Valves

March 8, 2018

Advertisement

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

COURAGE, FAME: Revascularization More Effective Than OMT

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

Long-Term Follow-up of the Platinum Chromium TAXUS Element (ION) Stent: PERSEUS Two-Year Results.

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Boston Scientific Announces its ACC 2011 Schedule

Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

DISRUPT CAD III: A deep dive on the U.S. pivotal study for coronary IVL

TopShock 2019: The Most Challenging Cases Simplified With IVL - Shockwave Medical

Evolution & Significance of Drug-Eluting Balloons for Coronary Intervention

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - OUS

The Growing Applications of Intravascular Lithotripsy (IVL) - Shockwave - US

Expanding Treatment Options for Patients with Severe Aortic Stenosis: The Lotus and ACURATE neo Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content